Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196
NCT04914936Phase 1Completed
- Sponsor
- Acerta Pharma
- Start
- Sep 2014
- Primary completion
- Oct 2014
- Countries
- 1
01
Overview
Phase 1, open-label trial of acalabrutinib tablet (Variant 1) in mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL) (3 arms), sponsored by Acerta Pharma. Primary endpoints: Area Under the Plasma Concentration-time Curve From Time 0 to Infinity at Day 9 and Maximum Observed Plasma Concentration at Day 9. Started Sep 2014; status: completed.
02
Drugs
acalabrutinib tablet (Variant 1)
03
Conditions
mantle cell lymphoma (MCL)chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT04914936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04914936.